India is looking to boost indigenous production and reduce by half its dependence on imports, especially from China, for critical pharmaceutical ingredients, with the launch of two new plants. To reduce import dependence on 'Key Starting Material' (KSM) and 'Active Pharmaceutical Ingredients' (API) in bulk […]
Source link
The country will become self-reliant in manufacturing of major pharma ingredients, import dependence will reduce by 50%.
